GE negotiating for Abbott diagnostics unit

Several news reports have surfaced that General Electric is close to a deal to buy the diagnostics unit of Abbott Laboratories for about $5 billion. A deal would greatly increase the size of GE's healthcare business, which has been focused on expanding its presence in IT as well as molecular diagnostics.

- read the AP's report on the talks

Suggested Articles

J&J's EGFR-fighting combo stopped tumor growth in 60% of patients whose lung cancer got worse after taking AstraZeneca's Tagrisso.

Amgen's KRAS inhibitor curbed tumor growth in 88% of patients with non-small cell lung cancer, shrinking tumors in one-third of them.

Novartis is forging ahead with the development of spartalizumab in "many, many other indications" despite the setback.